Electromedical Technologies, Inc.
EMEDOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$171008
P/E Ratio—
52W High$0.0002
52W Low$0.00005
Electromedical Technologies, Inc. (EMED) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EMED · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.04M | $0.59M | $1.35M | $1.15M | $0.91M |
| Cost of Revenue | $0.10M | $0.21M | $0.30M | $0.26M | $0.20M |
| Gross Profit | ($0.06M) | $0.38M | $1.05M | $0.89M | $0.71M |
| Gross Margin %(computed) | -150.94% | 64.79% | 77.51% | 77.28% | 78.04% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.23M | $0.09M | $0.22M |
| G&A Expenses | $0.00M | $0.00M | $2.25M | $1.90M | $3.83M |
| Total Operating Expenses | $0.95M | $1.45M | $3.11M | $2.49M | $4.51M |
| Operating Income | ($1.02M) | ($1.06M) | ($2.06M) | ($1.60M) | ($3.80M) |
| Operating Margin %(computed) | — | -180.99% | -153.09% | -139.46% | -418.83% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.16M | $0.23M | $0.89M | $0.79M | $3.31M |
| Income Before Tax | ($1.44M) | ($1.29M) | ($2.64M) | ($3.47M) | ($8.48M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($1.44M) | ($1.29M) | ($2.64M) | ($3.47M) | ($8.48M) |
| Net Margin %(computed) | — | -219.58% | -195.82% | -301.65% | -934.59% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $-0.00 | $-0.01 | $-0.03 | $-0.24 |
| Wtd Avg Shares | 2926.61M | 648.65M | 377.22M | 133.60M | 50.99M |
| EBITDA | ($0.92M) | ($1.01M) | ($1.72M) | ($2.66M) | ($5.14M) |
| EBITDA Margin %(computed) | — | -172.17% | -127.66% | -230.95% | -566.96% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Electromedical Technologies, Inc. data
About Electromedical Technologies, Inc. (EMED) Income Statement
Electromedical Technologies, Inc. (EMED) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EMED reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -150.94%), and net income of ($0.00B) — a net profit margin of -3495.26%.
Frequently asked questions
EMED · 4 questionsElectromedical Technologies, Inc. (EMED) reported revenue of $0.00B for 2025, down 93.0% year-over-year.
EMED revenueEMED salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09